Apr 28, 2020 - PepsiCo Indias third food manufacturing plant gets nod to re-start work

From the Editor's Desk

Popular heartburn medicine being studied as treatment for coronavirus

Over the past few weeks researchers have been discreetly studying a new potential treatment for COVID-19 -- and it might not be what you expect.

The treatment in question is called famotidine, and it's the active ingredient in Pepcid, an over-the-counter medication commonly used to alleviate heartburn.

Since March 13, researchers at Northwell Health, a network of hospitals in New York, have been enrolling patients hospitalized with COVID-19 into their study of famotidine, which is being delivered through an IV in megadoses nine times greater than the typical over-the-counter dose. The drug is being given in combination with the much-touted antimalarial hydroxychloroquine.

Continued here

TradeBriefs: What's important, not just what's popular!

Advertisers of the day

Emeritus: PG Diploma in Digital Business by Emeritus in collaboration with MIT Sloan & Columbia Business School Executive Education | Accepting Applications

Emeritus: Accepting Applications for the Postgraduate Diploma in Leadership | 6 Months, Online

Emeritus: PG Diploma in Innovation & Design Thinking | Accepting Applications

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.